Evotec and Sandoz plan potential sale of Toulouse biologics site

Published 30/07/2025, 11:14
Evotec and Sandoz plan potential sale of Toulouse biologics site

Evotec SE (NASDAQ:EVO) announced Wednesday that it is planning, together with Sandoz (SIX:SDZ) AG, a potential sale of the Just – Evotec Biologics site located in Toulouse, France. The information was disclosed in a press release statement included in the company’s latest filing with the U.S. Securities and Exchange Commission.

According to the filing, Evotec and Sandoz are considering the transaction as part of an evolution of their strategic partnership. The Toulouse site, operated under the Just – Evotec Biologics brand, is a facility focused on biologics development and manufacturing.

Details regarding the potential sale, including financial terms, timeline, and possible buyers, were not provided in the filing. The announcement states only that both companies are currently planning the transaction and have agreed on the potential sale.

Evotec SE is headquartered in Hamburg, Germany and is listed on the NASDAQ exchange under the ticker EVO. Sandoz AG is a global pharmaceutical company specializing in generic and biosimilar medicines.

The information is based on a press release statement contained in Evotec’s Form 6-K filed with the SEC.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.